Five minutes with David Llewellyn from DJS Antibodies
A dynamic new biotech started by Dr David Llewellyn and Dr Joe Illingworth, DJS Antibodies is pioneering the development of novel therapeutics to treat the world’s most critical inflammatory diseases, a class of disease that accounts for more than 50% of deaths worldwide.
Optellum wins NHS funding
Optellum wins NHS funding for its AI decision support to detect early-stage lung cancer this week.
Spintex wins Ray of Hope Prize!
Company based at Wood Centre for Innovation, Spintex wins the $100,000 Ray of Hope Prize this week. The prize is awarded each year to the world’s top nature-inspired start-up after 10 finalist teams conclude a 10-week accelerator program. Congratulations to Spintex!
DJS Antibodies moves to our newly-converted R&D labs
Biotech start-up, DJS Antibodies, is the second company to move into our newly-converted class II laboratory space at the Wood Centre for Innovation.
Five minutes with Peter Hamley from Samsara Therapeutics
We spoke to Peter Hamley, Chief Scientific Officer of amazing biotech start-up Samsara Therapeutics, who have just moved into the new life science labs at our Wood Centre for Innovation.
Createc’s ground-breaking Robot
Createc has been developing smart radiation detection and 3D gamma radiation mapping technology over the last few years. Their ‘N-Visage®’ sensor has been deployed worldwide, including at the Fukushima Daichi nuclear power plant in Japan after the devastating earthquake and tsunami in 2011.
New milestones for development of Cold Quanta’s Quantum Positioning System (QPS)
Based in our Oxford Centre for Innovation, Cold Quanta announces new milestones for its High-BIAS2 – or High Bandwidth Intertial Atom Source – project that moves the industry closer to safer skies with more precise inflight navigation systems.
Samsara takes new lab space at Wood Centre for Innovation
The £0.5m development – now underway – will deliver laboratory facilities to answer the significant demand that has been seen in the last year from science and tech start-ups and SMEs for lab space in Oxford’s Global Health and Life Sciences District, one of the UK’s leading technology clusters delivering lifesaving developments such as the COVID-19 vaccine.
